Karimzadeh Parvaneh, Bakrani Vahid
Pediatric Neurology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran ; Pediatric Neurology Department, Mofid Children Hospital, Faculty of Medicin, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mofid Children Hospital, Faculty of Medicin, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran J Child Neurol. 2013 Summer;7(3):25-9.
According to the basic role of drug side effects in selection of an appropriate drug, patient compliance and the quality of life in epileptic patients, and forasmuch as new drugs with unknown side effect have been introduced, necessity of this research is explained. This study was conducted to evaluate the incidence and clinical characteristics of anti epileptic drug (AED) related adverse reactions in children.
MATERIAL & METHODS: In this descriptive study, children less than 14 years old with AED side effects referred to the Children's Medical Center and Mofid Childeren's Hospital (Tehran, Iran) were evaluated during 2010-2012. The informations were: sex, age, incriminating drug, type of drug side effect, incubation period, history of drug usage, and patient and family allergy history. Exclusive criterions were age more than 14 years old and reactions due to reasons other than AEDs.
A total of 70 patients with AED reaction were enrolled in this study. They included 26 (37%) females and 44 (63%) males. The maximum rate of incidence was seen at age less than 5 years old. All the patients had cutaneous eruptions that the most common cutaneous drug eruption was maculopapular rash. The most common culprit was phenobarbital (70%) and the least common was lamotrigine (1.4%).
In this study, we found higher rates of drug rash in patients treated with aromatic AEDs and lower rates with non-aromatic AEDs. Various endogenous and environmental factors may influence the propensity to develop these reactions.
根据药物副作用在选择合适药物、患者依从性以及癫痫患者生活质量方面的基本作用,鉴于已引入副作用不明的新药,解释了本研究的必要性。本研究旨在评估儿童抗癫痫药物(AED)相关不良反应的发生率和临床特征。
在这项描述性研究中,对2010 - 2012年间转诊至儿童医学中心和莫菲德儿童医院(伊朗德黑兰)的14岁以下有AED副作用的儿童进行了评估。信息包括:性别、年龄、致病药物、药物副作用类型、潜伏期、用药史以及患者和家族过敏史。排除标准为年龄超过14岁以及由AED以外原因引起的反应。
本研究共纳入70例有AED反应的患者。其中女性26例(37%),男性44例(63%)。发病率最高的年龄段为5岁以下。所有患者均有皮肤疹,最常见的皮肤药物疹为斑丘疹。最常见的致病药物是苯巴比妥(70%),最不常见的是拉莫三嗪(1.4%)。
在本研究中,我们发现使用芳香族AED治疗的患者药物疹发生率较高,而非芳香族AED治疗的患者发生率较低。各种内源性和环境因素可能影响发生这些反应的倾向。